RxDoctor Payments Data

Margaret Andrews, DO

Family Medicine · Bel Air, MDNPI 1437563863

Payments from drug & device makers

$598in general payments, 2019–2025

Across 36 payments — averaging $16.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$200
  • AbbVie$102
  • Johnson & Johnson$52
  • Novo Nordisk$52
  • Amarin Pharma, Inc.$44
  • Amgen$37
  • plus $111 from 7 others

What the payments were for

  • Food & beverage$598100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$598 in reported general payments places this provider in the 60th percentile of 1,193 family medicine providers in Maryland.

See all family medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$42,808
Medicare patients
167
Services billed
437

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban26$32,496
XareltoRivaroxaban16$27,955
JardianceEmpagliflozin16$13,899
TradjentaLinagliptin12$6,533
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,068
Arnuity ElliptaFluticasone Furoate14$4,322
Breo ElliptaFluticasone/Vilanterol11$4,287
SynthroidLevothyroxine Sodium24$1,675
Albuterol Sulfate HfaAlbuterol Sulfate30$1,519
Atorvastatin Calcium107$1,339
Pravastatin Sodium41$906
Levothyroxine Sodium62$834
Valsartan23$807
Celecoxib11$685
Gabapentin26$627

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$52$27,95516 claims
GSKArnuity Ellipta, Breo Ellipta$25$8,60925 claims
AbbVieSynthroid$102$1,67524 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,193 family medicine providers in Maryland.

Other family medicine in Bel Air

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →